CS226025B2 - Method of preparing cephalosporine derivatives - Google Patents
Method of preparing cephalosporine derivatives Download PDFInfo
- Publication number
- CS226025B2 CS226025B2 CS809244A CS924480A CS226025B2 CS 226025 B2 CS226025 B2 CS 226025B2 CS 809244 A CS809244 A CS 809244A CS 924480 A CS924480 A CS 924480A CS 226025 B2 CS226025 B2 CS 226025B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- product
- group
- mixture
- acid
- dichloromethane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Laminated Bodies (AREA)
- Table Devices Or Equipment (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS813880A CS226028B2 (cs) | 1979-12-24 | 1981-05-26 | Způsob výroby cefalosporinových derivátů |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7931616A FR2472574A1 (fr) | 1979-12-24 | 1979-12-24 | Derives de cephalosporine et composition pharmaceutique les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS226025B2 true CS226025B2 (en) | 1984-03-19 |
Family
ID=9233132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS809244A CS226025B2 (en) | 1979-12-24 | 1980-12-23 | Method of preparing cephalosporine derivatives |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4463173A (no) |
| EP (1) | EP0031708B1 (no) |
| JP (1) | JPS56158787A (no) |
| AT (1) | ATE7918T1 (no) |
| AU (1) | AU544374B2 (no) |
| CA (1) | CA1175805A (no) |
| CS (1) | CS226025B2 (no) |
| DD (1) | DD155520A5 (no) |
| DE (1) | DE3068273D1 (no) |
| DK (1) | DK552480A (no) |
| ES (2) | ES8201167A1 (no) |
| FI (1) | FI803817L (no) |
| FR (1) | FR2472574A1 (no) |
| GR (1) | GR71920B (no) |
| HU (1) | HU186289B (no) |
| IL (1) | IL61775A (no) |
| MW (1) | MW5380A1 (no) |
| NO (1) | NO803903L (no) |
| NZ (1) | NZ195731A (no) |
| PH (1) | PH21662A (no) |
| PL (2) | PL132587B1 (no) |
| PT (1) | PT72265B (no) |
| SU (2) | SU1031408A3 (no) |
| YU (2) | YU324680A (no) |
| ZA (1) | ZA807710B (no) |
| ZM (1) | ZM11380A1 (no) |
| ZW (1) | ZW31280A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2496666A1 (fr) * | 1980-12-22 | 1982-06-25 | Ici Pharma | Nouveaux derives de cephalosporine et composition pharmaceutique les contenant |
| FR2496665A1 (fr) * | 1980-12-23 | 1982-06-25 | Ici Pharma | Nouveaux derives de penicilline et composition pharmaceutique les contenant |
| ZA824094B (en) * | 1981-06-19 | 1983-07-27 | Ici Plc | A process for the manufacture of cephalosporin derivative |
| EP0071370A3 (en) * | 1981-07-23 | 1984-05-16 | Ici Pharma | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
| US4504478A (en) * | 1981-09-18 | 1985-03-12 | Imperial Chemical Industries Plc | Cephalosporin-1-oxide derivatives |
| EP0082648A3 (en) * | 1981-12-21 | 1984-09-26 | Imperial Chemical Industries Plc | Cephalosporin derivatives |
| JPS59110695A (ja) * | 1982-12-16 | 1984-06-26 | Asahi Chem Ind Co Ltd | 経口用セフアロスポリン |
| GR78718B (no) * | 1983-01-31 | 1984-09-27 | Ici Pharma | |
| US4855420A (en) * | 1983-06-03 | 1989-08-08 | Ici Pharma | Cephalosporin derivatives |
| GB8316589D0 (en) * | 1983-06-17 | 1983-07-20 | Ici Plc | Crystalline salts |
| US4547573A (en) * | 1983-12-02 | 1985-10-15 | Ici Pharma | Process for preparing cephalosporin derivatives |
| EP0215435B1 (en) * | 1985-09-09 | 1993-03-03 | Otsuka Pharmaceutical Co., Ltd. | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same |
| US4760140A (en) * | 1986-10-20 | 1988-07-26 | American Cyanamid Company | 3-substituted-7-[5-substituted-2-thiazolyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid, diphenylmethyl esters |
| US6476220B2 (en) * | 2000-11-27 | 2002-11-05 | Aurobindo Pharma Limited | Process for the preparation of furaca |
| US20030135041A1 (en) | 2002-01-04 | 2003-07-17 | Orchid Chemicals & Pharmaceuticals Limited, India | Synthesis of ceftiofur intermediate |
| MX2011003239A (es) * | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos. |
| WO2015042438A1 (en) * | 2013-09-19 | 2015-03-26 | The Florida International Board Of Trustees Modesto A. Maidique Campus | Selective inhibition of bacterial topoisomerase i |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2430375A1 (de) * | 1973-06-26 | 1975-03-20 | Leo Pharm Prod Ltd | 7-amino-delta hoch 3 -cephem-4-carbonsaeure-derivate |
| US4255424A (en) * | 1979-04-27 | 1981-03-10 | Merck & Co., Inc. | 7-N-Heterocyclyl 1-oxa, 1-aza, and 1-carbadethiacephalosporins |
| EP0018595B1 (en) * | 1979-04-27 | 1986-08-20 | Merck & Co. Inc. | 7-n-heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same |
| US4358447A (en) * | 1979-04-27 | 1982-11-09 | Merck & Co., Inc. | 7-N-Heterocyclyl cephalosporins |
| US4282219A (en) * | 1979-08-01 | 1981-08-04 | Merck & Co., Inc. | 7-N-Heterocyclyl cephalosporins and antibiotic pharmaceutical compositions containing them |
-
1979
- 1979-12-24 FR FR7931616A patent/FR2472574A1/fr not_active Withdrawn
-
1980
- 1980-12-01 GR GR63516A patent/GR71920B/el unknown
- 1980-12-03 NZ NZ195731A patent/NZ195731A/en unknown
- 1980-12-05 AU AU65134/80A patent/AU544374B2/en not_active Ceased
- 1980-12-09 FI FI803817A patent/FI803817L/fi not_active Application Discontinuation
- 1980-12-09 ZA ZA00807710A patent/ZA807710B/xx unknown
- 1980-12-17 HU HU803021A patent/HU186289B/hu unknown
- 1980-12-18 ZW ZW312/80A patent/ZW31280A1/xx unknown
- 1980-12-19 MW MW53/80A patent/MW5380A1/xx unknown
- 1980-12-20 PH PH24974A patent/PH21662A/en unknown
- 1980-12-21 IL IL61775A patent/IL61775A/xx unknown
- 1980-12-22 NO NO803903A patent/NO803903L/no unknown
- 1980-12-22 AT AT80304674T patent/ATE7918T1/de not_active IP Right Cessation
- 1980-12-22 YU YU03246/80A patent/YU324680A/xx unknown
- 1980-12-22 DE DE8080304674T patent/DE3068273D1/de not_active Expired
- 1980-12-22 PT PT72265A patent/PT72265B/pt unknown
- 1980-12-22 EP EP80304674A patent/EP0031708B1/en not_active Expired
- 1980-12-23 CA CA000367478A patent/CA1175805A/en not_active Expired
- 1980-12-23 PL PL1980228757A patent/PL132587B1/pl unknown
- 1980-12-23 PL PL1980232847A patent/PL133508B1/pl unknown
- 1980-12-23 SU SU803219703A patent/SU1031408A3/ru active
- 1980-12-23 DD DD80226584A patent/DD155520A5/de unknown
- 1980-12-23 CS CS809244A patent/CS226025B2/cs unknown
- 1980-12-23 DK DK552480A patent/DK552480A/da not_active Application Discontinuation
- 1980-12-23 ZM ZM113/80A patent/ZM11380A1/xx unknown
- 1980-12-24 US US06/219,879 patent/US4463173A/en not_active Expired - Lifetime
- 1980-12-24 JP JP18365980A patent/JPS56158787A/ja active Granted
- 1980-12-24 ES ES498157A patent/ES8201167A1/es not_active Expired
-
1981
- 1981-04-24 SU SU813274748A patent/SU1077573A3/ru active
- 1981-05-20 ES ES502352A patent/ES502352A0/es active Granted
-
1982
- 1982-12-31 YU YU02926/82A patent/YU292682A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6346904B2 (ja) | ベータ−ラクタマーゼ阻害剤 | |
| CS226025B2 (en) | Method of preparing cephalosporine derivatives | |
| JP6403219B2 (ja) | ベータ−ラクタマーゼ阻害剤 | |
| NZ192762A (en) | Penicillin derivatives and pharmaceutical and veterinary compositions | |
| AU2010271732A1 (en) | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer | |
| CA3081751A1 (en) | Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same | |
| US20150152083A1 (en) | Compounds and Compositions for Modulating EGFR Activity | |
| JPS58198490A (ja) | 化学的化合物 | |
| AU2002211827B2 (en) | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | |
| CA3005779C (en) | Cephem compounds, their production and use | |
| JPS61140586A (ja) | 外部においてアルキル化された単環または二環の２‐第四級ヘテロアリールアルキル置換基を持つカルバペネム及び１‐メチルカルバペネム | |
| JP6343034B2 (ja) | ナフチリジンジオン誘導体 | |
| JPH05506033A (ja) | 抗微生物性キノロニルラクタム類 | |
| JP2011530580A (ja) | 強力なｈｓｐ−９０阻害剤としての２−アミノピリミジン化合物 | |
| US4863914A (en) | Penem derivatives | |
| JP6526064B2 (ja) | ピリドピリミジンジオン誘導体 | |
| JPS6118785A (ja) | ペネム誘導体 | |
| JPS60142987A (ja) | セフアロスポリン誘導体 | |
| AT398421B (de) | Neue penamderivate und deren salze, verfahren zur herstellung derselben und dieselben enthaltende antibakterielle mittel | |
| AU2013326408A1 (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses | |
| JPS6310792A (ja) | 新規セフエム化合物 | |
| CS232743B2 (en) | Method of cephalosporine preparation | |
| JPS5989683A (ja) | カルバペネム抗生物質 | |
| CS236471B2 (en) | Method of cephalosporines production | |
| JPS61171488A (ja) | セフアロスポリン誘導体、その製法及び該化合物を含有する抗菌性医薬組成物 |